...
首页> 外文期刊>BARC Newsletter >Development of ~(90)Sr-~(90)Y Generator Systems for Radio Therapeutic Applications
【24h】

Development of ~(90)Sr-~(90)Y Generator Systems for Radio Therapeutic Applications

机译:放射治疗应用〜(90)Sr-〜(90)Y发生器系统的开发

获取原文
获取原文并翻译 | 示例
           

摘要

~(90)Y in carrier-free form is a potential therapeutic radioisotope due to its several desirable nuclear properties. It is a pure beta emitter with 64. ih half life and 2.28 MeV energy formed by the decay of ~(90)Sr. ~(90)Sr is available in good yield during the fission of heavy nuclides and can be recovered in large quantities from high level liquid waste originating from PUREX process used in spent fuel reprocessing and is an ideal source for generator applications due to its long half life. A number of generator systems based on solvent extraction, ion exchange, extraction chromatography, electrochemical etc. are reported in literature, but none of them satisfy the requirement of an ideal system for use in radiopharmaceutical centers. Purity of the product and ease in handling of the system are the two major requirements. This has prompted to develop a generator system for routine application. Feed ~(90)Sr and solvents used in these studies are of indigenous origin. The techniques used have been progressively changed from extraction chromatography through single membrane cell to the current two membrane cell configuration. The present paper describes the step by step evolution of the generator system based on supported liquid membrane technique to its current status. The system is currently configured at an ideal level of 100 mCi for routine use and can be multiplied with additional units as per demand. During the course of generator development, a simple and novel quality control technique based on extraction paper chromatography was also perfected for the first time.
机译:无载体形式的〜(90)Y由于其几种理想的核性质而具有潜在的治疗意义。它是纯的β发射极,具有半衰期为64.ih,由〜(90)Sr衰减形成的能量为2.28 MeV。 〜(90)Sr在重核素裂变过程中可获得高收率,并且可以从乏燃料后处理中使用的PUREX工艺产生的大量废液中大量回收,并且由于其半衰期长,因此是发电机应用的理想来源生活。文献中报道了许多基于溶剂萃取,离子交换,萃取色谱,电化学等的发生器系统,但是它们均不能满足用于放射性药物中心的理想系统的要求。产品的纯度和系统的易操作性是两个主要要求。这促使开发用于常规应用的发电机系统。这些研究中使用的〜(90)Sr饲料和溶剂是本地来源的。所使用的技术已从萃取色谱法通过单膜细胞逐步转变为当前的两膜细胞配置。本文描述了基于支持的液膜技术的发电机系统到目前状态的逐步发展。该系统当前配置为日常使用的理想水平100 mCi,并且可以根据需要与其他单位相乘。在发生器的开发过程中,还首次完善了基于萃取纸色谱的简单新颖的质量控制技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号